A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a multi-center, randomized, double-blind, placebo-controlled study in patients with moderate to severe plaque psoriasis.
Epistemonikos ID: 0df9442695ef7fd5b7f4394be392227c53a5b183
First added on: May 14, 2024